AXGN
Axogen IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$2.27B
P/E Ratio
—
EPS
$-0.63
Beta
1.17
52W High
$45.83
52W Low
$9.22
50-Day MA
$33.98
200-Day MA
$25.98
Dividend Yield
—
Profit Margin
-13.20%
Forward P/E
370.37
PEG Ratio
99.04
About Axogen Inc
AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida.
Fundamentals
| Revenue (TTM) | $238.10M |
| Gross Profit (TTM) | $178.61M |
| EBITDA | $-2.13M |
| Operating Margin | -4.61% |
| Return on Equity | -18.00% |
| Return on Assets | -2.32% |
| Revenue/Share (TTM) | $5.00 |
| Book Value | $2.73 |
| Price-to-Book | 9.40 |
| Price-to-Sales (TTM) | 9.52 |
| EV/Revenue | 9.33 |
| EV/EBITDA | 4083.53 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 26.60% |
| Shares Outstanding | $53.18M |
| Float | $52.03M |
| % Insiders | 2.05% |
| % Institutions | 87.21% |
Historical Volatility
HV 10-Day
48.37%
HV 20-Day
63.22%
HV 30-Day
59.72%
HV 60-Day
55.42%
HV Rank
61.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($50.78 target)
2
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026